Monitoring health products on the Canadian market
We monitor the compliance of health products on the market through proactive activities such as compliance monitoring projects. Learn more about these activities below.
On this page
- How we monitor compliance
- How we select products and activities for compliance monitoring
- What we do as part of our monitoring
- After we review compliance
- Completed reports on compliance monitoring
- Who is responsible for the safety of health products in Canada
- How to report a complaint
- For more information
How we monitor compliance
Health Canada is responsible for helping Canadians maintain and improve their health. Our compliance and enforcement activities help protect you against health and safety risks. We monitor the compliance of health products on the market in different ways. One way we do this is through proactive compliance monitoring projects (CMP).
Health products must meet legislative and regulatory requirements in order to be legally sold in Canada. These requirements are outlined in the Food and Drugs Act and its regulations. For example, a product licence is required for:
- natural health products (NHPs)
- medical devices (except Class I devices)
When we issue a licence, it means we have reviewed the safety of the product before it goes to market.
Companies must also meet requirements when they perform certain activities related to health products.
For example, a licence is required to:
- fabricate, package, label, distribute, import, wholesale, or test a drug (Drug Establishment Licence)
- fabricate, import, package or label a natural health product (Site Licence)
- with some exceptions, fabricate, sell or import medical devices (Medical Device Establishment Licence)
How we select products and activities for compliance monitoring
Compliance monitoring projects are usually focused on specific types of products or activities. For example, we may choose a product that has had an increasing number of complaints or an activity that can have a large impact on product quality. Through these projects, we collect information that helps us to determine if there are additional problems with products on the market.
What we do as part of our monitoring
During compliance monitoring, inspectors may check that health products:
- don't pose a risk to health
- contain what they say they should
- list necessary information on their label
- are licensed for sale in Canada (if a licence is required)
- make only health claims that they're authorized to make (called terms of market authorization)
Inspectors may also verify that a regulated party's activities are conducted in accordance with relevant requirements.
Compliance monitoring is conducted to complement our complaint-based verifications and routine inspection programs for health products. We use compliance monitoring to gather more information on specific issues or as opportunity for compliance promotion. Many regulated parties involved in our compliance monitoring projects use them as a chance to clarify the requirements in order to follow them better.
After we review compliance
When an inspector finds a product or an activity that doesn't meet legislative and regulatory requirements, we:
- clarify what's necessary to achieve compliance
- take action according to our Compliance and Enforcement Policy (POL-0001) such as;
- requesting a voluntary stop of sale
- suspensions of a company's site or establishment licence
- suspension of a product's licence
It's then the regulated party's responsibility to take timely and appropriate action to comply with requirements.
We will inform you about any unsafe products by posting:
- recall notices and public advisories
- reports outlining the findings from compliance monitoring projects
Completed reports on compliance monitoring
Once a project is completed, we make the results available to the public. Browse the completed reports.
Who is responsible for the safety of health products in Canada
The safety of heath products including human drugs, NHPs and medical devices, is a shared responsibility between:
- product licence holders
- companies that conduct activities such as manufacture, package, label or import health products
- Health Canada
Product licence holders
Product licence holders are responsible for:
- ensuring that they're complying with Canada's regulatory requirements
- applying for and receiving a product licence before a product can be legally sold in Canada
- keeping their product licences up to date
Product licences include a Drug Identification Number (DIN) for drugs, a Natural Product Number (NPN) or a homeopathic Drug Identification Number (DIN-HM) for NHPs or a Medical Device Licence (Class II, III or IV) for medical devices.
Companies that conduct activities related to health products such as manufacturing, packaging, labelling or importing are responsible for:
- applying for, receiving and maintaining the appropriate establishment or site licence prior to conducting their activities
- follow the requirements for Good Manufacturing Practices or ISO, which are described in the relevant regulations.
- ensure the products they handle follow all other requirements set out in the regulations, including those about product quality
Retailers must verify whether they require an establishment or site license if they conduct activities beyond selling health products (for example, importation). They are responsible for making sure that the health products they sell have a valid product licence.
It's our responsibility to regulate the safety and quality of health products. We use a number of ways to confirm that health products are meeting regulatory requirements, such as:
- examining products at the border
- responding to complaints
- conducting compliance monitoring projects
- monitoring international information
- testing products at our Laboratories
We take action when a company or product isn't complying with the Food and Drugs Act or its regulations. Actions taken are based on the risk posed to Canadians.
Usually, we achieve compliance through a cooperative approach with the regulated party, but if needed, we will take the necessary actions to address non-compliance to reduce the risk to Canadians. The primary objective of Health Canada's compliance and enforcement approach is to manage the risks to Canadians using the most appropriate level of intervention.
How to report a complaint
We want to hear from you if you have a complaint about a health product or a company that handles health products. Report it by using the health product complaint form.
Adverse reactions to health products can be reported to Canada Vigilance using the online reporting form.
For more information
Report a problem or mistake on this page
- Date modified: